Skip to main content

Table 4 Thromboembolic events according to chemotherapy regimen

From: Thromboembolic events in cancer patients on active treatment with cisplatin-based chemotherapy: another look!

Chemotherapy Regimen

Number of Patients

Thromboembolic Events

(n)

%

Cisplatin-XRT

299

13

4.3

Cisplatin-Docetaxel-5FU

245

31

12.7

Cisplatin-Docetaxel

194

13

6.7

DHAP

180

3

1.7

Cisplatin-Etoposide

145

3

2.1

Cisplatin-5FU

120

9

7.5

BEP

116

5

4.3

Cisplatin-Gemcitabine

95

9

9.5

Cisplatin-Doxorubicin

42

3

7.1

Cisplatin-Etoposide-XRT

38

4

10.5

ECF

30

9

30.0

Cisplatin-Pemetrexed

19

3

15.8

Others

154

5

3.2

  1. 5-FU 5-Flurouracil, DHAP Dexamethasone, High-dose
  2. Ara-C and Cisplatin; BEP Bleomycin, Etoposide and Cisplatin, ECF Epirubicin, Cisplatin and 5-Flurouracil, XRT Radiation therapy